Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;39(2):344-53.
doi: 10.1007/s00259-011-1967-x. Epub 2011 Nov 10.

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis

Martin Fuchs  1 , Matthias Briel, Thomas Daikeler, Ulrich A Walker, Helmut Rasch, Scott Berg, Quinn K T Ng, Heike Raatz, David Jayne, Ina Kötter, Daniel Blockmans, Maria C Cid, Sergio Prieto-González, Peter Lamprecht, Carlo Salvarani, Zaharenia Karageorgaki, Richard Watts, Raashid Luqmani, Jan Müller-Brand, Alan Tyndall, Martin A Walter
Affiliations
Free article

The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis

Martin Fuchs et al. Eur J Nucl Med Mol Imaging. 2012 Feb.
Free article

Abstract

Purpose: We aimed to assess the impact of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) on the management of patients with suspected large vessel vasculitis.

Methods: An international expert panel determined diagnoses and clinical management in patients with suspected large vessel vasculitis, with and without the results of (18)F-FDG PET, respectively. The accuracy of the clinical diagnosis and the resulting clinical management with and without the (18)F-FDG PET results were compared using logistic regression models.

Results: The analysis included 30 patients referred to a tertiary care centre with large vessel vasculitis and 31 controls. (18)F-FDG PET had an overall sensitivity of 73.3% [95% confidence interval (CI) 54.1-87.7%], a specificity of 83.9% (95% CI 66.3-94.5%), a positive predictive value of 81.5% (95% CI 61.9-93.7%) and a negative predictive value of 76.5% (95% CI 58.8-89.3%). The diagnostic accuracy of (18)F-FDG PET was higher in patients not receiving immunosuppressive drugs (93.3 vs 64.5%, p = 0.006). Taken in context with other available diagnostic modalities, the addition of (18)F-FDG PET increased the clinical diagnostic accuracy from 54.1 to 70.5% (p = 0.04). The addition of (18)F-FDG PET increased the number of indicated biopsies from 22 of 61 patients (36.1%) to 25 of 61 patients (41.0%) and changed the treatment recommendation in 8 of 30 patients (26.7%) not receiving immunosuppressive medication and in 7 of 31 patients (22.6%) receiving immunosuppressive medication.

Conclusion: (18)F-FDG PET is a sensitive and specific imaging tool for large vessel vasculitis, especially when performed in patients not receiving immunosuppressive drugs. It increases the overall diagnostic accuracy and has an impact on the clinical management in a significant proportion of patients.

PubMed Disclaimer

References

    1. Ann Rheum Dis. 2010 Oct;69(10):1744-50 - PubMed
    1. Clin Nucl Med. 2008 Dec;33(12):872-3 - PubMed
    1. J Nucl Med. 2002 May;43(5):652-7 - PubMed
    1. J Nucl Med. 2002 May;43(5):658-63 - PubMed
    1. Am J Med. 2004 Jan 1;116(1):50-3 - PubMed

Publication types

MeSH terms